Daewoong Pharmaceutical Targets 300 Billion Won in Digital Health Sales... "Nationwide 24-Hour Health Monitoring"

Head of Division Park Hyungcheol: "Achieving 300 Billion Won in Sales This Year
Building a Digital Safety Net Connecting Healthcare Professionals and Patients"

Daewoong Pharmaceutical has declared the beginning of a "nationwide 24-hour health monitoring era," in which hospitals and homes are organically connected to provide real-time patient care.

On the 23rd, Daewoong Pharmaceutical held a press conference at JW Marriott Hotel Dongdaemun in Dongdaemun-gu, Seoul, and, together with its partner companies, unveiled the integrated AI healthcare platform "All-New thynC." The event went beyond a simple technology showcase and was filled with vivid insights from experts in industry, academia, and research, focusing on solving workforce shortages in clinical settings and maximizing patient safety.

Park Hyungcheol, Head of the ETC Division at Daewoong Pharmaceutical, is presenting at the 'Daewoong Pharmaceutical Digital Healthcare Solution Press Briefing' held at the JW Marriott Hotel Dongdaemun on the 23rd. Daewoong Pharmaceutical

Daewoong Pharmaceutical's "All-New thynC" platform unifying fragmented medical data

Park Hyungcheol, Head of ETC Marketing at Daewoong Pharmaceutical, highlighted the value of connection enabled by the company’s "thynC" platform. Park said, "If only there had been a connected system capable of relaying information to someone, the outcome could have been different," adding, "The 24-hour monitoring that Daewoong Pharmaceutical pursues is about building connections that reduce the moments when no one is watching." He continued, "The vision we promised last year of 'faster, closer, and smarter' is now being realized in actual clinical settings," and expressed confidence by saying, "We aim to establish this as an essential technology that creates a win-win-win for companies, healthcare professionals, and patients, and to achieve 300 billion won in digital healthcare sales by 2026."

Lee Yeongshin, CEO of Seas Technology, who led the technological advancement of the core platform All-New thynC, explained the direction of the platform’s evolution. Lee said, "Over the past year, we have upgraded the algorithms and integrated remote collaborative care functions, reflecting improvement needs from clinical sites," and evaluated that "All-New thynC has now proven that it is evolving beyond a simple vital-sign monitoring device into core infrastructure for smart wards." Lee added the ambition to "build a full-lifecycle monitoring infrastructure that connects the entire patient journey, from inpatients to home care and even the pre-hospital stage for emergency patients."

CEOs of partner companies that joined the integrated platform emphasized innovation in their respective areas of expertise and expressed confidence in the synergy. Jo Jaehyung, CEO of iCoop, underscored the importance of continuous glucose monitoring solutions, saying, "By moving away from painful needle-based blood sampling and sharing real-time data, we can enhance both patient safety and healthcare staff efficiency." In particular, Jo explained, "One of the key advantages of the integrated platform is that it enables immediate determination, through real-time blood glucose data, of whether a patient whose heart rate is increasing is experiencing hypoglycemia or if there is another cause." Park Seonhee, Executive Director at Skylabs, introduced the ring-type blood pressure monitor "Cart-On," noting, "Despite being an essential vital sign, blood pressure is difficult to measure automatically, and it has been a major workload burden for nurses," and emphasized, "By enabling automatic measurement and recording, we will create an environment where nurses can focus on their core work of patient observation and emergency response."

Kim Yongsik, CEO of Puzzle AI, who supports the digitization of medical records through AI voice recognition technology, stressed the importance of data accuracy. Kim said, "Without records, there is no medical care, yet traditional medical records have often been incomplete or missing," and added, "By combining CL NOTE technology, which generates real-time summarized notes from spoken words and links them to the EMR, with All-New thynC, we have secured a level of data accuracy and scalability that has never been seen before."

On the 23rd at JW Marriott Hotel Dongdaemun in Dongdaemun-gu, Seoul, a press conference was held for the integrated AI healthcare platform All-New thynC. From the left in the photo, Park Hyungcheol, Head of ETC Hospital Division at Daewoong Pharmaceutical; Lee Youngshin, CEO of Seers Technology; Yang Munsul, Chairman of the Korea Hospital Association; Lee Gyumin, President of the Association of Nurses for Small and Medium Hospitals; Jo Jaehyung, CEO of iCoop; Park Sunhee, Managing Director at Skylabs; and Kim Yongsik, CEO of Puzzle AI, are speaking. Photo by Jeong Donghun

Medical staff: "Digital healthcare is essential infrastructure for improving patient safety and treatment efficiency"

Support also came from experts who are directly responsible for real-world clinical settings. Yang Munsul, Chair of the Future Healthcare Committee at the Korean Hospital Association, said, "Until now, medical professionals have detected changes in patients’ conditions through sacrifices that felt like grinding down their own bones, but we have now hit a limit," and predicted, "Digital healthcare will become an important tool for filling workforce gaps and a powerful weapon for gaining insights into patients through accumulated data." Lee Gyumin, President of the Association of Small and Medium-Sized Hospital Nurses, likewise testified to changes on the ground. Lee said, "In the past, nurses had to visit each patient room one by one, but after the system was introduced, we have been able to grasp patients’ conditions at a glance from a central location," and added, "It plays a solid supporting role in filling management blind spots in integrated nursing-care service wards without caregivers and during night shifts."

Starting with this press conference, Daewoong Pharmaceutical plans to expand the number of beds covered by All-New thynC to 100,000 and to target the out-of-hospital home-care market by linking it with the chronic disease management platform "Wellcheck." Park concluded, "The greatest significance of this partnership lies in the fact that innovative technologies from each field have begun to operate as a single system in actual clinical settings," and added, "We will continue to prove overwhelming results as a partner that supports clinical decision-making and protects patients’ lives."